You are here

  • Home
  • Online First
  • Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer

Article info

Article menu

other Versions

Download PDFPDF
Original Article
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer

Authors

  • Jennifer Taylor Veneris Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Lei Huang Center for Research Informatics, The University of Chicago, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Jane E Churpek Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Suzanne D Conzen Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA Ben May Department for Cancer Biology, The University of Chicago, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Gini F Fleming Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Jennifer Taylor Veneris, Division of Gynecologic Oncology Program, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Jennifer_Veneris{at}dfci.harvard.edu
View Full Text

Citation

Veneris JT, Huang L, Churpek JE, et al
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer
International Journal of Gynecologic Cancer Published Online First: 25 January 2019. doi: 10.1136/ijgc-2018-000101

Publication history

  • Received August 27, 2018
  • Revision received December 7, 2018
  • Accepted December 12, 2018
  • First published January 25, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.